• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染和疫苗接种的T细胞免疫反应

T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination.

作者信息

Notarbartolo Samuele

机构信息

Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

出版信息

Vaccines (Basel). 2024 Sep 30;12(10):1126. doi: 10.3390/vaccines12101126.

DOI:10.3390/vaccines12101126
PMID:39460293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11511197/
Abstract

The innate and adaptive immune systems collaborate to detect SARS-CoV-2 infection, minimize the viral spread, and kill infected cells, ultimately leading to the resolution of the infection. The adaptive immune system develops a memory of previous encounters with the virus, providing enhanced responses when rechallenged by the same pathogen. Such immunological memory is the basis of vaccine function. Here, we review the current knowledge on the immune response to SARS-CoV-2 infection and vaccination, focusing on the pivotal role of T cells in establishing protective immunity against the virus. After providing an overview of the immune response to SARS-CoV-2 infection, we describe the main features of SARS-CoV-2-specific CD4 and CD8 T cells, including cross-reactive T cells, generated in patients with different degrees of COVID-19 severity, and of Spike-specific CD4 and CD8 T cells induced by vaccines. Finally, we discuss T-cell responses to SARS-CoV-2 variants and hybrid immunity and conclude by highlighting possible strategies to improve the efficacy of COVID-19 vaccination.

摘要

先天性免疫系统和适应性免疫系统协同作用,以检测新型冠状病毒2(SARS-CoV-2)感染、减少病毒传播并杀死被感染细胞,最终使感染得到解决。适应性免疫系统会对先前接触过的病毒产生记忆,当再次受到同一病原体攻击时会产生更强的反应。这种免疫记忆是疫苗功能的基础。在此,我们综述了当前关于对SARS-CoV-2感染和疫苗接种的免疫反应的知识,重点关注T细胞在建立针对该病毒的保护性免疫中的关键作用。在概述了对SARS-CoV-2感染的免疫反应后,我们描述了SARS-CoV-2特异性CD4和CD8 T细胞的主要特征,包括在不同程度的新型冠状病毒肺炎(COVID-19)严重程度患者中产生的交叉反应性T细胞,以及疫苗诱导的刺突蛋白(Spike)特异性CD4和CD8 T细胞。最后,我们讨论了T细胞对SARS-CoV-2变体的反应和混合免疫,并通过强调提高COVID-19疫苗效力的可能策略来得出结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9c/11511197/6145bea4efdc/vaccines-12-01126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9c/11511197/7fc9a9aa695b/vaccines-12-01126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9c/11511197/c0c76d776dd5/vaccines-12-01126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9c/11511197/89313d869d96/vaccines-12-01126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9c/11511197/6145bea4efdc/vaccines-12-01126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9c/11511197/7fc9a9aa695b/vaccines-12-01126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9c/11511197/c0c76d776dd5/vaccines-12-01126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9c/11511197/89313d869d96/vaccines-12-01126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9c/11511197/6145bea4efdc/vaccines-12-01126-g004.jpg

相似文献

1
T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染和疫苗接种的T细胞免疫反应
Vaccines (Basel). 2024 Sep 30;12(10):1126. doi: 10.3390/vaccines12101126.
2
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
3
Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV.在 HIV 感染者中,不同的 SARS-CoV-2 疫苗平台可诱导产生稳健的疫苗诱导的体液免疫和细胞免疫反应。
Microbiol Spectr. 2023 Jun 15;11(3):e0115523. doi: 10.1128/spectrum.01155-23. Epub 2023 May 11.
4
Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.人类对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的先天性和适应性免疫反应:与获得性免疫和疫苗反应的相关性
Clin Exp Immunol. 2021 Jun;204(3):310-320. doi: 10.1111/cei.13582. Epub 2021 Mar 4.
5
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.mRNA 疫苗诱导的 T 细胞对 SARS-CoV-2 关切变异株的反应完全相同,但根据先前的感染状态,其持久性和归巢特性存在差异。
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.
6
Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination.解析 SARS-CoV-2 的体液免疫:感染和疫苗接种的启示。
Hum Antibodies. 2024;32(3):85-106. doi: 10.3233/HAB-230017.
7
Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy.异基因造血干细胞移植治疗髓系恶性肿瘤的患者对 COVID-19 mRNA 疫苗的特异性免疫反应会受到免疫抑制治疗的影响。
Leuk Res. 2023 Jul;130:107314. doi: 10.1016/j.leukres.2023.107314. Epub 2023 May 16.
8
Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.雾化卡介苗接种对恒河猴 SARS-CoV-2 挑战后免疫和疾病参数的影响。
Front Immunol. 2022 Feb 9;12:801799. doi: 10.3389/fimmu.2021.801799. eCollection 2021.
9
Adaptive immune responses and cytokine immune profiles in humans following prime and boost vaccination with the SARS-CoV-2 CoronaVac vaccine.人类在接种 SARS-CoV-2 科兴疫苗的基础免疫和加强免疫后,适应性免疫反应和细胞因子免疫特征。
Virol J. 2022 Dec 22;19(1):223. doi: 10.1186/s12985-022-01957-1.
10
Predominantly defective CD8 T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients.肺移植受者对 SARS-CoV-2 mRNA 疫苗接种的主要缺陷性 CD8 T 细胞免疫。
J Transl Med. 2023 Jun 8;21(1):374. doi: 10.1186/s12967-023-04234-z.

引用本文的文献

1
Hematologic and Immunologic Overlap Between COVID-19 and Idiopathic Pulmonary Fibrosis.新型冠状病毒肺炎与特发性肺纤维化之间的血液学和免疫学重叠
J Clin Med. 2025 Jul 24;14(15):5229. doi: 10.3390/jcm14155229.
2
Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV)-Vaccinated Individuals in a Group of Venezuelan Admixed Volunteers.探索对SARS-CoV-2的免疫反应:来自一组委内瑞拉混血志愿者中接种国药集团(BBIBP-CorV)疫苗个体的见解。
Biomedicines. 2025 Jun 25;13(7):1550. doi: 10.3390/biomedicines13071550.
3
Latent tuberculosis coinfection in mild COVID-19 is associated with a distinct immune cell phenotype marked by enhanced cytotoxic degranulation and mitochondrial alterations.

本文引用的文献

1
SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination.mRNA疫苗接种后,骨髓长期存在的细胞区室中不会持久建立SARS-CoV-2特异性浆细胞。
Nat Med. 2025 Jan;31(1):235-244. doi: 10.1038/s41591-024-03278-y. Epub 2024 Sep 27.
2
Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia.肺泡 T 细胞反应的独特进化与未接种疫苗的 SARS-CoV-2 肺炎患者的临床结局相关。
Nat Immunol. 2024 Sep;25(9):1607-1622. doi: 10.1038/s41590-024-01914-w. Epub 2024 Aug 13.
3
Efficacy and safety of COVID-19 vaccination in solid organ transplant recipients: A systematic review and network meta-analysis.
轻度新冠肺炎中的潜伏性结核合并感染与一种独特的免疫细胞表型相关,其特征为细胞毒性脱颗粒增强和线粒体改变。
Front Immunol. 2025 May 19;16:1566449. doi: 10.3389/fimmu.2025.1566449. eCollection 2025.
4
Immune Imprinting, Non-Durable Hybrid Immunity, and Hybrid Immune Damping Following SARS-CoV-2 Primary Vaccination with BNT162b2 and Boosting with mRNA-1273.SARS-CoV-2初次接种BNT162b2并使用mRNA-1273加强免疫后的免疫印记、非持久性混合免疫和混合免疫抑制
Vaccines (Basel). 2025 Mar 13;13(3):310. doi: 10.3390/vaccines13030310.
COVID-19 疫苗在实体器官移植受者中的疗效和安全性:系统评价和网络荟萃分析。
Am J Transplant. 2024 Dec;24(12):2269-2281. doi: 10.1016/j.ajt.2024.07.031. Epub 2024 Jul 31.
4
Immunological memory diversity in the human upper airway.人类上呼吸道中的免疫记忆多样性。
Nature. 2024 Aug;632(8025):630-636. doi: 10.1038/s41586-024-07748-8. Epub 2024 Jul 31.
5
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.人类 SARS-CoV-2 挑战揭示了局部和全身反应动力学。
Nature. 2024 Jul;631(8019):189-198. doi: 10.1038/s41586-024-07575-x. Epub 2024 Jun 19.
6
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges.用新城疫病毒载体的严重急性呼吸综合征冠状病毒2疫苗进行鼻内接种可抵御德尔塔和奥密克戎毒株的挑战。
NPJ Vaccines. 2024 May 23;9(1):90. doi: 10.1038/s41541-024-00870-8.
7
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development.鼻腔内接种二价 SARS-CoV-2 疫苗可有效保护小鼠免受鼻腔感染,并完全抑制疾病发展。
Vaccine. 2024 Jun 20;42(17):3664-3673. doi: 10.1016/j.vaccine.2024.04.079. Epub 2024 May 6.
8
The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling study.通用冠状病毒疫苗的潜在流行病学、临床和经济价值:一项建模研究。
EClinicalMedicine. 2024 Jan 11;68:102369. doi: 10.1016/j.eclinm.2023.102369. eCollection 2024 Feb.
9
SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination.严重急性呼吸综合征冠状病毒2(SARS-CoV-2):感染和疫苗接种引发的固有免疫反应一瞥
Antibodies (Basel). 2024 Feb 8;13(1):13. doi: 10.3390/antib13010013.
10
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission.经鼻内接种减毒的 SARS-CoV-2 疫苗可限制病毒传播。
Nat Commun. 2024 Feb 2;15(1):995. doi: 10.1038/s41467-024-45348-2.